These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2467907)

  • 1. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels.
    Sugita Y; Nakano Y; Tomita M
    J Biochem; 1988 Oct; 104(4):633-7. PubMed ID: 2467907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS; Wood LM; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
    J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of decay-accelerating factor (DAF) from rabbit erythrocyte membranes.
    Sugita Y; Uzawa M; Tomita M
    J Immunol Methods; 1987 Nov; 104(1-2):123-30. PubMed ID: 2445823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization of active complement receptor type 1 (CR1) from human erythrocyte stroma with trypsin and its purification.
    Sugita Y; Nakano Y; Tomita M
    J Biochem; 1986 Nov; 100(5):1193-200. PubMed ID: 2950080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of the terminal complement complex from target sheep erythrocyte membranes.
    Bhakdi S; Ey P; Bhakdi-Lehnen B
    Biochim Biophys Acta; 1976 Feb; 419(3):445-57. PubMed ID: 1247570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
    Zalman LS; Brothers MA; Müller-Eberhard HJ
    J Immunol; 1989 Sep; 143(6):1943-7. PubMed ID: 2476489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human platelet and red blood cell plasma membrane proteins by preparative detergent electrophoresis.
    Nichols WL; Gastineau DA; Mann KG
    Biochim Biophys Acta; 1979 Jul; 554(2):293-308. PubMed ID: 486443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement induces a transient increase in membrane permeability in unlysed erythrocytes.
    Halperin JA; Nicholson-Weller A; Brugnara C; Tosteson DC
    J Clin Invest; 1988 Aug; 82(2):594-600. PubMed ID: 3403718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.
    Kolb WP; Muller-Eberhard HJ
    J Exp Med; 1975 Apr; 141(4):724-35. PubMed ID: 47885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size of the transmembrane channels produced by complement proteins C5b-8.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1982 Sep; 129(3):1143-6. PubMed ID: 6286757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and purification of a 90-kDa membrane-bound endogenous inhibitor of multicatalytic proteinase from human erythrocytes.
    Khan MT; Wang K; Roufogalis BD
    Biochem Biophys Res Commun; 1995 Sep; 214(3):957-62. PubMed ID: 7575569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic photolabeling in membranes: the human erythrocyte glucose transporter.
    Lala AK; Bhat S
    Biotechnol Appl Biochem; 1990 Oct; 12(5):586-94. PubMed ID: 2288716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.